Glaxosmithkline



Ebit Zmiana Data
AbbVie USD 5.72B 69M 2025-06
Amgen USD 2.26B 1.34B 2025-06
AstraZeneca USD 3.51B 1.3B 2025-06
Aurora Cannabis CAD 36.86M 39.25M 2024-12
Bausch Health Companies USD 605M 18M 2025-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Canopy Growth CAD -23822000 22.12M 2024-12
Corcept Therapeutics USD 26.67M 23.26M 2025-06
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 7.02B 3.32B 2025-06
GlaxoSmithKline GBP 2.07B 462M 2025-06
Glaxosmithkline GBP 1.83B 1.76B 2024-12
J&J USD 6.94B 443M 2025-06
Merck USD 6.36B 149M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Pacira USD 10.23M 2.21M 2025-06
Perrigo USD 55.6M 91M 2025-06
Pfizer USD 2.6B 3.33B 2025-06
Prestige Brands USD 71.76M 29.14M 2025-06
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 1.51B 1.39B 2025-06
Supernus Pharmaceuticals USD 12.14M 14.74M 2025-06
Takeda JPY 257.79B 387.52B 2025-06
Teva Pharmaceutical Industries USD 406M 540M 2025-06
Zoetis USD 1.02B 106M 2025-06


Glaxosmithkline - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.